Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$134K Sell
372
-1
-0.3% -$342 0.03% 97
2026
Q1
$131K Buy
373
+2
+0.5% +$713 0.04% 93
2025
Q4
$121K Sell
371
-20
-5% -$6.34K 0.03% 93
2025
Q3
$110K Sell
391
-13
-3% -$3.77K 0.03% 104
2025
Q2
$112K Buy
404
+16
+4% +$4.53K 0.03% 96
2025
Q1
$121K Buy
388
+166
+75% +$49K 0.04% 88
2024
Q4
$58K Buy
222
+1
+0.5% +$297 0.02% 109
2024
Q3
$71K Buy
221
+2
+0.9% +$654 0.02% 91
2024
Q2
$68K Buy
219
+1
+0.5% +$294 0.02% 89
2024
Q1
$61K Sell
218
-10
-4% -$2.93K 0.02% 99
2023
Q4
$65K Hold
228
0.02% 90
2023
Q3
$61K Buy
228
+10
+5% +$2.5K 0.02% 103
2023
Q2
$48K Hold
218
0.02% 107
2023
Q1
$52K Buy
+218
New +$53.5K 0.02% 101
2020
Q2
Sell
-50
Closed -$10K 190
2020
Q1
$10K Hold
50
0.01% 115
2019
Q4
$12K Buy
+50
New +$11K 0.01% 126

Other funds holding AMGN

Ogorek Anthony Joseph's AMGN Position: Q2 2026 in Review

Ogorek Anthony Joseph reduced its Amgen (AMGN) stake by 0.27% in Q2 2026, selling an estimated $342 and leaving 372 shares worth $134K. The position accounts for 0.03% of the portfolio, ranked #97.

Ogorek Anthony Joseph first reported a position in AMGN in Q4 2019 and has held it in 16 quarters since. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Ogorek Anthony Joseph held 372 shares of Amgen worth $134K as of Q2 2026.
  • Ogorek Anthony Joseph sold 1 Amgen share in Q2 2026, an estimated $342.
  • Amgen made up 0.03% of Ogorek Anthony Joseph's portfolio in Q2 2026, its #97 holding.
  • Ogorek Anthony Joseph first reported a position in Amgen in Q4 2019 and has held it in 16 quarters since.
  • 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Ogorek Anthony Joseph's 13F filing for Q2 2026, filed 7 Aug 2026.